Drug Search Results
More Filters [+]

glucose

Alternative Names: glucose
Latest Update: 2024-11-12
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Zhejiang University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for glucose

Countries in Clinic: Austria, China, Denmark, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom

Active Clinical Trial Count: 16

Highest Development Phases

Phase 3: Colorectal Cancer|Diabetic Foot|Kidney Diseases|Kidney Failure, Chronic|Prostate Cancer|Soft Tissue Infections

Phase 2: Common Cold|Glycogen Storage Disease Type Ia|Nasopharyngitis|Type 2 Diabetes

Phase 1: Angina Pectoris|Coronary Disease|Healthy Volunteers|Myocardial Infarction

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

IP-001-18

P3

Unknown Status

Kidney Diseases

2025-12-31

IP-001-21

P3

Unknown Status

Kidney Diseases

2024-12-31

ELIXIR

P3

Recruiting

Kidney Failure, Chronic

2024-12-01

49%

2-DG-02

P2

Recruiting

Common Cold|Nasopharyngitis

2024-08-31

24%

Recent News Events